SIRT1 and mixed phenotype acute leukemia: Another recent study found that SIRT1 knockout can prevent age-dependent mixed phenotype acute leukemia (MPAL) and HSC aging, suggesting a potential future avenue for treating MPAL and modifying the functions of aging HSCs (Wang et al., 2022).